Evaluation of Maintenance Capecitabine Therapy After First-Line Chemotherapy in Metastatic Pancreatic Cancer.
Maintenance capecitabine after first-line modified FOLFIRINOX in patients with metastatic pancreatic cancer was well tolerated and may enhance PFS and OS while maintaining an acceptable quality of life.